Future Microbiology logo Future Medicine logo

Future Microbiology provides cutting-edge coverage of advances our understanding of microbial organisms and corresponding treatment strategies and agents in infectious disease. The journal also addresses the molecular basis of disease, epidemiologic trends and advanced diagnostic technologies.

Publisher: Future Medicine

Volume 2, Number 5, October 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Community-associated MRSA: a dangerous epidemic
pp. 457-459(3)
Author: Otto, Michael

Virulent mycobacteria and the many aspects of macrophage uptake
pp. 461-464(4)
Authors: Danelishvili, Lia; Cirillo, Suat LG; Cirillo, Jeffrey D; Bermudez, Luiz E

Bulletin Board

Conference Scene

Microbial Pathogenesis: Mechanisms of Infectious Disease
pp. 469-472(4)
Author: Schultz-Cherry, Stacey

Priotity Paper Evaluation

Priority Paper Evaluation

Role of sequential therapy in Helicobacter pylori eradication therapy
pp. 481-484(4)
Authors: Pajares-Garcia, Jose Maria; Villarroya, Ramon Pajares; Gisbert, Javier P

Special Report

European regulatory conundrum of phage therapy
pp. 485-491(7)
Authors: Verbeken, Gilbert; De Vos, Daniel; Vaneechoutte, Mario; Merabishvili, Maya; Zizi, Martin; Pirnay, Jean-Paul

The US National Antimicrobial Resistance Monitoring System
pp. 493-500(8)
Authors: Gilbert, Jeffrey M; White, David G; McDermott, Patrick F

Review

Carbapenemases: molecular diversity and clinical consequences
pp. 501-512(12)
Authors: Poirel, Laurent; Pitout, Johann D; Nordmann, Patrice

Expanding role of lipid II as a target for lantibiotics
pp. 513-525(13)
Authors: Martin, Nathaniel I; Breukink, Eefjan

New imaging tools for the diagnosis of infection
pp. 527-554(28)
Authors: Walker, Ronald C; Jones-Jackson, Laurie B; Martin, William; Habibian, M Reza; Delbeke, Dominique

Communication systems in the genus Burkholderia: global regulators and targets for novel antipathogenic drugs
pp. 555-563(9)
Authors: Sokol, Pamela A; Malott, Rebecca J; Riedel, Kathrin; Eberl, Leo

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A